Article
Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy.
Viral immunology - 1 May 2016
Abdel-Hameed Enass A, Rouster Susan D, Ji Hong, Ulm Ashley, Hetta Helal F, Anwar Nadeem, Sherman Kenneth E, Shata Mohamed Tarek M
Abstract excerpt
The efficacy of protease inhibitor drugs in hepatitis C virus (HCV) treatment is limited by the selection and expansion of drug-resistant mutations. HCV replication is error-prone and genetic variability within the dominant epitopes ensures its persistence. The aims of this study are to evaluate the role of cellular immune response in the emergence of HCV protease resistance mutations and its effects on treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
